Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer’s-related psychosis during the latter part of the year.
Bristol Myers Squibb says Alzheimer’s is the biggest market for new schizophrenia drug
Date:
More like thisRelated
RRB ALP Recruitment 2025: Apply for 9,970 vacancies from April 12; check selection process and other details here
The RRB ALP Recruitment 2025 application process for 9,970...
‘Gauti (Gautam Gambhir) bhai has helped me understand my potential’
Washington Sundar, a versatile all-rounder, faces the challenge of...
Apple is left without a life raft as Trump’s China trade war intensifies, analysts warn
Apple remains stranded without a life raft, experts say,...